Celestica (CLS)
(Delayed Data from NYSE)
$63.06 USD
+1.81 (2.96%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $63.25 +0.19 (0.30%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.06 USD
+1.81 (2.96%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $63.25 +0.19 (0.30%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Zacks News
All You Need to Know About Celestica (CLS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Celestica (CLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Celestica (CLS) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of 20.00% and 1.35%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Celestica (CLS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Analysts Estimate Celestica (CLS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celestica (CLS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of 8.33% and 5.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Celestica (CLS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celestica (CLS) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Celestica (CLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Jabil (JBL) Catches Eye: Stock Jumps 7.8%
by Zacks Equity Research
Jabil (JBL) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Itron (ITRI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Itron (ITRI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Celestica (CLS) Q2 Earnings Meet Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of 0.00% and -0.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Factors Setting the Tone for Celestica (CLS) in Q2 Earnings
by Zacks Equity Research
Celestica's (CLS) Q2 earnings are likely to benefit from synergies from Impakt and Atrenne buyouts; and solid adoption of JDM solutions. However, soft demand from OEM customers remains headwind.
Is Celestica (CLS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.
Earnings Preview: Celestica (CLS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Celestica (CLS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Do Options Traders Know Something About Celestica (CLS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Celestica (CLS) stock based on the movements in the options market lately.
Earnings Preview: Celestica (CLS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Do Fed Doves Foretell?
by John Blank
Doves say 0 hikes in 2019, and maybe 1 rate cut in 2020.
Rates Hikes or No Rate Hikes?
by John Blank
0 Hikes, 1 Hike or 2 Hikes in 2019?
Should Value Investors Buy Celestica (CLS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Celestica (CLS) Misses Q4 Earnings Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of -6.45% and 0.67%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Industry Rank Highlights: Jabil and Celestica
by Zacks Equity Research
The Zacks Industry Rank Highlights: Jabil and Celestica
Follow Wearables to a Hot Industry Niche
by John Blank
Electronics Manufacturing Services (EMS) is at #11 out of 256 industries (in the top 4%) within the Zacks Industry Ranks.
Moving Average Crossover Alert: Celestica (CLS)
by Zacks Equity Research
Celestica Inc. (CLS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Celestica (CLS) Q3 Earnings Miss Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of -13.33% and 1.21%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?